Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions
Convatec (LSE:CTEC), a leading medical products and technologies company focused on solutions for the management of chronic conditions; The Eli Lilly and Company Foundation (Lilly Foundation), a tax-exempt private foundation supported by donations from Eli Lilly and Company (NYSE:LLY) have committed c.$5 million to Partners In Health (PIH), an international nonprofit global health organization to help accelerate the integration of non‑communicable disease (NCD) and chronic care, including cardiometabolic and mental health, into primary and community health systems in resource-limited settings.
The financial commitment will enable PIH to scale its integrated models of care and support efforts to embed sustainable approaches to the prevention, diagnosis and management of NCDs and other chronic conditions within shifting healthcare systems.
For Convatec, the commitment represents the next phase of its collaboration with PIH, building on work since 2023 that has already reached more than 300,000 people. The initiative honours the legacy of Karim Bitar, formerly Chief Executive Officer of Convatec before he passed away in October 2025, whose belief in the power of collective action and long‑term healthcare partnerships continues to inspire many people.
